Towie, we have been watching the inaction of this stock for months. Today's "action" doesn't look like the occasional spec to me. I'm starting to think that there IS something going on.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress